“Molecular Docking Study, and In Vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone Against Breast Cancer Cell Line (MCF-7)”. Al Mustansiriyah Journal of Pharmaceutical Sciences 22, no. 3 (October 24, 2022): 24–34. Accessed April 25, 2025. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/886.